October 11, 2017 / 5:57 AM / 2 months ago

BRIEF-Biophytis completes EUR 10.4 million capital increase

Oct 11 (Reuters) - BIOPHYTIS SA:

* BIOPHYTIS SA - BIOPHYTIS COMPLETES A €10.4 M CAPITAL INCREASE TO FINANCE MID-STAGE CLINICAL TRIALS FOR TWO NOVEL ANTI-AGING DRUG-CANDIDATES

* ‍ISSUES 1,989,000 NEW ORDINARY SHARES AT A PRICE OF EUR 5.25 PER SHARE​

* ‍SHARE PRICE IS REPRESENTING DISCOUNT OF 9% BASED ON WEIGHTED AVERAGE PRICE OVER LAST 10 TRADING DAYS BEFORE PRICING​

* ‍TOTAL AMOUNT OF OPERATION REPRESENTS 20% OF SHARE CAPITAL OF COMPANY​

* ‍CAPITAL WILL BE INCREASED VIA ISSUANCE OF NEW SHARES WITHOUT SHAREHOLDERS’ PREFERENTIAL SUBSCRIPTION RIGHTS​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below